Multiple sclerosis may disrupt endocannabinoid brain protection mechanism.
Shohami
Esther
E
Department of Pharmacology and Medicinal Chemistry, Hebrew University, Medical Faculty, Jerusalem 91120, Israel.
Mechoulam
Raphael
R
D000818:Animals; D001921:Brain / Q000378:metabolism*; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000378:metabolism*; D063388:Endocannabinoids; D051379:Mice; D009103:Multiple Sclerosis / Q000378:metabolism*; D018696:Neuroprotective Agents / Q000378:metabolism*
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D018696:Neuroprotective Agents